gliclazide has been researched along with Blood Pressure, High in 21 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of exposure to gliclazide and ramipril during pregnancy in a patient with diabetes mellitus and hypertension." | 7.75 | Normal pregnancy and healthy child after continued exposure to gliclazide and ramipril during pregnancy. ( Akar, M; Kolagasi, O; Sari, F; Sari, R, 2009) |
| "The subject is a diabetic and hypertensive woman treated early during an unplanned pregnancy with a multi-drug regimen that included three drugs with no prior history for use in pregnant women (rosiglitazone, gliclazide, atorvastatin)." | 7.72 | Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman. ( Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Yaris, E; Yaris, F, 2004) |
| "In type 2 diabetic patients, the vasodilating response to forearm ischemia was the same whether patients were treated with diet treatment alone or with glibenclamide or glimepiride at blood glucose-lowering equipotent closes." | 5.09 | Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia. ( Brunelli, C; Cordera, R; Cordone, S; Olivotti, L; Rossettin, P; Schiavo, M; Spallarossa, P, 2001) |
| "To report a case of exposure to gliclazide and ramipril during pregnancy in a patient with diabetes mellitus and hypertension." | 3.75 | Normal pregnancy and healthy child after continued exposure to gliclazide and ramipril during pregnancy. ( Akar, M; Kolagasi, O; Sari, F; Sari, R, 2009) |
| "The subject is a diabetic and hypertensive woman treated early during an unplanned pregnancy with a multi-drug regimen that included three drugs with no prior history for use in pregnant women (rosiglitazone, gliclazide, atorvastatin)." | 3.72 | Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman. ( Kadioglu, M; Kalyoncu, NI; Kesim, M; Ulku, C; Yaris, E; Yaris, F, 2004) |
| "Weight loss is strongly recommended for overweight and obese adults with type 2 diabetes." | 2.94 | The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE. ( Chalmers, J; Hamet, P; Harrap, S; Lee, AK; Marre, M; Mcevoy, JW; Ohkuma, T; Selvin, E; Sharrett, AR; Wang, D; Warren, B; Williams, B; Woodward, M, 2020) |
| "A total of 11 140 patients with type 2 diabetes mellitus were randomly assigned to fixed combination of perindopril-indapamide (4/1." | 2.79 | Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial. ( Arima, H; Chalmers, J; Harrap, S; Hirakawa, Y; Mancia, G; Patel, A; Poulter, N; Williams, B; Woodward, M; Zoungas, S, 2014) |
| "In patients with type 2 diabetes, moderate alcohol use, particularly wine consumption, is associated with reduced risks of cardiovascular events and all-cause mortality." | 2.79 | The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes. ( Blomster, JI; Chalmers, J; Chow, CK; Harrap, S; Hillis, GS; Li, Q; Mancia, G; Neal, B; Patel, A; Poulter, N; Williams, B; Woodward, M; Zoungas, S, 2014) |
| "A post hoc analysis of patients with type 2 diabetes followed by the ADVANCE-ON (Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation - Observational Study)." | 1.72 | Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With Diabetes. ( Chalmers, J; Hamet, P; Harrap, S; Harris, K; Mancia, G; Poulter, N; Rodgers, A; Wang, N; Williams, B; Woodward, M; Zoungas, S, 2022) |
| " Long-term use of metformin in complex multifactorial therapy of women with decompensated type 2 diabetes DM, AH and abdominal obesity provides improvement of carbohydrate and lipid metabolism, lowering of arterial pressure, diminishment of albuminuria, diastolic dysfunction, and stiffness of left ventricular myocardium." | 1.36 | [Dynamics of structural-functional parameters of cardiovascular system during use of complex therapy of women with type 2 diabetes mellitus]. ( Elsukova, OS; Onuchin, SG; Onuchina, EL; Solov'ev, OV, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (4.76) | 18.2507 |
| 2000's | 11 (52.38) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 2 (9.52) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, N | 1 |
| Harris, K | 1 |
| Hamet, P | 5 |
| Harrap, S | 7 |
| Mancia, G | 5 |
| Poulter, N | 5 |
| Williams, B | 6 |
| Zoungas, S | 5 |
| Woodward, M | 7 |
| Chalmers, J | 10 |
| Rodgers, A | 2 |
| Lee, AK | 1 |
| Wang, D | 2 |
| Ohkuma, T | 1 |
| Warren, B | 1 |
| Sharrett, AR | 1 |
| Marre, M | 4 |
| Mcevoy, JW | 2 |
| Selvin, E | 2 |
| Raslan, IA | 1 |
| McDonald, EG | 1 |
| Lee, TC | 1 |
| Juraschek, SP | 1 |
| Lazo, M | 1 |
| Cooper, ME | 2 |
| Arima, H | 2 |
| Hirakawa, Y | 2 |
| Patel, A | 7 |
| Yamout, H | 1 |
| Bakris, GL | 1 |
| Blomster, JI | 1 |
| Li, Q | 2 |
| Chow, CK | 1 |
| Neal, B | 4 |
| Hillis, GS | 1 |
| Billot, L | 1 |
| Monaghan, H | 2 |
| Joshi, R | 3 |
| Colagiuri, S | 1 |
| Glasziou, P | 2 |
| Grobbee, D | 2 |
| Heller, S | 2 |
| Lisheng, L | 2 |
| Matthews, DR | 1 |
| Mogensen, CE | 1 |
| Perkovic, V | 4 |
| MacMahon, S | 2 |
| Kolagasi, O | 1 |
| Sari, F | 1 |
| Akar, M | 1 |
| Sari, R | 1 |
| Walker, J | 1 |
| White, R | 1 |
| Vale, A | 1 |
| Elliott, S | 1 |
| Wass, J | 1 |
| Reynolds, J | 1 |
| de Galan, BE | 1 |
| Ninomiya, T | 1 |
| Cass, A | 1 |
| Pillai, A | 1 |
| Travert, F | 1 |
| Onuchin, SG | 1 |
| Elsukova, OS | 1 |
| Solov'ev, OV | 1 |
| Onuchina, EL | 1 |
| Chaturvedi, V | 1 |
| Currie, R | 1 |
| Yaris, F | 1 |
| Yaris, E | 1 |
| Kadioglu, M | 1 |
| Ulku, C | 1 |
| Kesim, M | 1 |
| Kalyoncu, NI | 1 |
| Hartsleben, ChH | 1 |
| Battegay, E | 1 |
| Kengne, AP | 1 |
| Nagy, V | 1 |
| Davis, TM | 1 |
| Parsons, RW | 1 |
| Broadhurst, RJ | 1 |
| Hobbs, MS | 1 |
| Jamrozik, K | 1 |
| Spallarossa, P | 1 |
| Schiavo, M | 1 |
| Rossettin, P | 1 |
| Cordone, S | 1 |
| Olivotti, L | 1 |
| Cordera, R | 1 |
| Brunelli, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study[NCT00949286] | 8,494 participants (Actual) | Observational | 2010-01-31 | Completed | |||
| ADVANCE - Action in Diabetes and Vascular Disease: Preterax and Diamicron - MR Controlled Evaluation[NCT00145925] | Phase 3 | 11,140 participants (Actual) | Interventional | 2001-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for gliclazide and Blood Pressure, High
| Article | Year |
|---|---|
Diabetes and vascular disease: a new international trial.
Topics: Antihypertensive Agents; Developing Countries; Diabetes Complications; Diabetes Mellitus; Diabetic A | 2003 |
New insights from ADVANCE.
Topics: Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Complications; Diabetes Mellitus, T | 2007 |
10 trials available for gliclazide and Blood Pressure, High
| Article | Year |
|---|---|
The Risks of Cardiovascular Disease and Mortality Following Weight Change in Adults with Diabetes: Results from ADVANCE.
Topics: Adult; Aged; Body-Weight Trajectory; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Drug Combin | 2020 |
Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial.
Topics: Aged; Antihypertensive Agents; Blood Glucose; Deoxyglucose; Diabetes Mellitus, Type 2; Drug Therapy, | 2019 |
Effects of combination of perindopril, indapamide, and calcium channel blockers in patients with type 2 diabetes mellitus: results from the Action In Diabetes and Vascular Disease: Preterax and Diamicron Controlled Evaluation (ADVANCE) trial.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, T | 2014 |
The relationship between alcohol consumption and vascular complications and mortality in individuals with type 2 diabetes.
Topics: Aged; Alcohol Drinking; Antihypertensive Agents; Coronary Disease; Diabetes Mellitus, Type 2; Diabet | 2014 |
Follow-up of blood-pressure lowering and glucose control in type 2 diabetes.
Topics: Antihypertensive Agents; Blood Glucose; Diabetes Mellitus, Type 2; Drug Combinations; Female; Follow | 2014 |
Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
Topics: Aged; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; | 2009 |
ADVANCE: breaking new ground in type 2 diabetes.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Mellitus, Type 2; Diuretics | 2006 |
[Advanced credit: patient enrolling and therapy initiation in the ADVANCE trial].
Topics: Adult; Aged; Antihypertensive Agents; Blood Glucose; Blood Pressure; Diabetes Complications; Diabete | 2007 |
Sulfonylurea treatment of type 2 diabetic patients does not reduce the vasodilator response to ischemia.
Topics: Aged; Aged, 80 and over; Blood Pressure; Brachial Artery; Diabetes Mellitus, Type 2; Diet, Diabetic; | 2001 |
Study rationale and design of ADVANCE: action in diabetes and vascular disease--preterax and diamicron MR controlled evaluation.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Clinical Protocols; Diabetes Mellitus, Type 2; Diabe | 2001 |
9 other studies available for gliclazide and Blood Pressure, High
| Article | Year |
|---|---|
Cumulative Systolic Blood Pressure Load and Cardiovascular Risk in Patients With Diabetes.
Topics: Blood Pressure; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Gliclazide; Heart Disease Risk F | 2022 |
Missed Opportunities for Deprescription: A Teachable Moment.
Topics: Aged, 80 and over; Deprescriptions; Diabetes Complications; Diabetes Mellitus; Drug Therapy, Combina | 2017 |
Evidence-based triple antihypertensive therapy yields lower mortality in older patients with diabetes mellitus.
Topics: Calcium Channel Blockers; Diabetes Mellitus, Type 2; Dihydropyridines; Drug Combinations; Female; Gl | 2014 |
Normal pregnancy and healthy child after continued exposure to gliclazide and ramipril during pregnancy.
Topics: Adult; Diabetes Mellitus, Type 2; Female; Gliclazide; Humans; Hypertension; Infant, Newborn; Live Bi | 2009 |
Unexplained severe hypoglycaemia in hospital: a difficult diagnostic challenge.
Topics: Aged; Cholecystectomy; Diabetes Mellitus, Type 2; Gliclazide; Humans; Hypertension; Hypoglycemia; Ma | 2009 |
[Dynamics of structural-functional parameters of cardiovascular system during use of complex therapy of women with type 2 diabetes mellitus].
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Chi-Square Distribution; Data Interpretation, Statis | 2010 |
Normal pregnancy outcome following inadvertent exposure to rosiglitazone, gliclazide, and atorvastatin in a diabetic and hypertensive woman.
Topics: Adult; Anxiety Disorders; Apgar Score; Atorvastatin; Chronic Disease; Diabetes Complications; Epilep | 2004 |
[54-year-old patient with type 2 diabetes mellitus and increased blood pressure values].
Topics: Antihypertensive Agents; Blood Pressure Determination; Combined Modality Therapy; Coronary Disease; | 2005 |
Arrhythmias and mortality after myocardial infarction in diabetic patients. Relationship to diabetes treatment.
Topics: Adult; Arrhythmias, Cardiac; Diabetes Complications; Diabetes Mellitus; Digitalis Glycosides; Diuret | 1998 |